Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02203903
Title Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies (RESOLVE)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catherine Bollard
Indications

mantle cell lymphoma

leukemia

chronic myeloid leukemia

anaplastic large cell lymphoma

Hodgkin's lymphoma

gray zone lymphoma

myelodysplastic syndrome

lymphoma

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

MultiTAA-specific T cells

Age Groups: child | adult | senior
Covered Countries USA


No variant requirements are available.